Elray Resources, Inc. - Mar 27, 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
10%+ Owner
Signature
Elray Resources, Inc., by /s/ Anthony Brian Goodman, CEO
Stock symbol
ATNF
Transactions as of
Mar 27, 2025
Transactions value $
$0
Form type
4
Date filed
4/11/2025, 06:05 PM
Previous filing
Dec 31, 2024
Next filing
Aug 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Conversion of derivative security +1.32M 1.32M Mar 27, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Series B Convertible Preferred Stock Conversion of derivative security $0 -1M -100% $0.00 0 Mar 27, 2025 Common Stock 1.32M Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein.
F2 Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock.
F3 The Series B Convertible Preferred Stock has no expiration date.